Work Comp Advised to Monitor Drug Shortage Situation

Drug shortages have been increasing in number and lasting longer, according to a new report from the FDA that blames the problem in part on a lack of incentives for manufacturers to produce less profitable medicines. Older drugs that have been off-patent for many years are especially vulnerable to shortages, the U.S. Food and Drug Administration said in the report issued this week. Congress requested the report in June 2018. “Manufacturers of older generic drugs, in particular, face intense price competition, uncertain revenue streams and high investment requirements, all of which...